- •Calcium-binding by proteins
- •Calmodulin and troponin C
- •Kinases regulated by calmodulin
- •Calcium-dependent enzymes that are not regulated by calmodulin
- •Paradigms of calcium signalling
- •Triggering neurotransmitter secretion
- •Initiation of contraction in skeletal muscle
- •Smooth muscle contraction
- •References
Calcium effectors
Calmodulin and troponin C
Calmodulin
Calmodulin and its isoform troponin C are the most prominent Ca2 -sensing proteins in animal cells. Calmodulin itself is highly conserved and present
at significant levels in all eukaryotic cells. In mammalian brain it comprises about 1% of the total protein. Calmodulin, through its interaction with Ca2 , can cause the activation of more than 100 different enzymes, that are not necessarily themselves Ca2 -sensitive (see Table 8.1). The most important effectors of Ca2 -calmodulin are shown in Figure 8.1.
Calmodulin first came to light in association with cyclic nucleotide phosphodiesterase.3,4 It is an acidic protein of modest size (17 kDa), consisting of a single, predominantly helical polypeptide chain with four Ca2 -binding EF-hands, two at each end (Figure 8.2b). The affinities of the individual Ca2 binding sites are in the range 10 5–10 6 mol L 1 and adjacent sites bind Ca2 with positive cooperativity, so that attachment of the first Ca2 ion enhances the affinity of its neighbour. This has the effect of making the protein sensitive to small changes in the concentration of Ca2 within the signalling range. Ca2 - calmodulin itself has no intrinsic catalytic activity. Its actions depend on its close association with a target enzyme, in some instances, as in phosphorylase kinase and calcineurin, acting as a permanent component of a multisubunit complex.
In the absence of bound Ca2 , the helices of calmodulin pack so that their hydrophobic side chains are not exposed. In this form it is unable to interact with its targets (Figure 8.2a). Binding of Ca2 to the four sites induces a large conformational change causing the terminal helices to expose hydrophobic
Fig 8.1 Multiple signal transduction pathways activated by calmodulin. Calmodulin bound to Ca2 interacts with and activates many enzymes, opening up a wide range of cellular responses. Abbreviations: MAP-2, microtubule-associated protein-2; Tau, tubulin assembly unit.
225
Signal Transduction
Fig 8.2 Three-dimensional structure of apocalmodulin, Ca2 -bound calmodulin, and calmodulin bound to a target peptide.
(a) Ca2 -free or apocalmodulin) (b) Calmodulin with four bound Ca2 ions (blue spheres). The terminal helices now expose hydrophobic residues (not indicated). (c) Calmodulin bound to a peptide corresponding to the calmodulin-binding domain of smooth muscle myosin light chain kinase (1cfd,5 cll1,6 and 2bbm7).
surfaces and also a long central -helical segment (Figure 8.2b).8 Ca2 -bound calmodulin binds to its targets with high affinity (KD 10 9 mol L 1). To form the bound state, the central residues of the link region unwind from their -helical arrangement to form a hinge that allows the molecule to bend and wrap itself around the target. The N- and C-terminal regions approach each other and by their hydrophobic surfaces bind to it, rather like two hands holding a rope. This encourages the target sequence to adopt an -helical arrangement so that it occupies the centre of a hydrophobic tunnel (Figure 8.2c). The consequence of this interaction is a conformational change in the target, a state that persists only
as long as the Ca2 concentration remains high. When it falls, Ca2 dissociates and calmodulin is quickly released, inactivating the target. However, at least one important target protein is an exception to this rule. This is CaM-kinase II which can retain its active state after it has been activated by calmodulin (see below).
Troponin C
Troponin C, which regulates the interaction of actin and myosin in striated muscle, is effectively an isoform of calmodulin. It also possesses two pairs of Ca2 -binding EF-hands located at opposite ends of a peptide chain.
The affinities of these sites for Ca2 lie between 10 5 and 10 7 mol L 1. Its function is described below (page 237).
Kinases regulated by calmodulin
Among the enzymes controlled by calmodulin are a number of serine/ threonine kinases. These include phosphorylase kinase, myosin light chain kinase (MLCK), and members of the family of Ca2 -calmodulin-dependent kinases (CaM-kinases). Each of these interacts with calmodulin to convert a Ca2 signal into a phosphorylation signal.
226
Calcium effectors
Fig 8.3 Calmodulin and Ca2 stimulate the breakdown of glycogen and inhibit its synthesis in skeletal muscle.
Phosphorylase kinase and glycogen synthase kinase
Phosphorylase kinase was the first protein kinase to be discovered.9 It is controlled by protein kinase A under -adrenergic stimulation and also through the effect of Ca2 on calmodulin (Figure 8.3). Even in the absence of Ca2 , calmodulin forms a permanent, integral subunit of phosphorylase kinase.10 When [Ca2 ] rises above the resting level, the kinase is activated both through its endogenous calmodulin and through the binding of an exogenous Ca2 -calmodulin. The enzyme catalyses glycogenolysis. To reinforce this, glycogen synthesis is simultaneously inhibited through the action of Ca2 -calmodulin
on glycogen synthase kinase, which phosphorylates and inactivates glycogen synthase (Figure 8.3). These themes will be developed further in Chapters 9 and 21 (page 679), where we shall see that phosphorylase kinase is also activated by a phosphorylation mediated by the second messenger cyclic AMP (cAMP).
227
Signal Transduction
Myosin light chain kinase
MLCK functions in smooth muscle, where it phosphorylates the light chain of myosin II to activate contraction. This is described in more detail below
(see page 239).
Ca2 -calmodulin activated protein kinases
On the basis of in vitro phosphorylation assays the CaM kinases have been termed multifunctional, suggesting that each member of the family
phosphorylates a broad range of physiological targets. The range of substrates observed in vivo, however, is not so wide. All of the CaM kinases possess an autoinhibitory domain that folds over the active site. The calmodulin binding site overlaps this domain and when Ca2 -calmodulin binds, the domain is released and the inhibition is lifted. Like many other kinases, the CaM kinases are also regulated by phosphorylation.11 The different isoforms (CaMKI–IV) are as follows.
CaMKI
This is ubiquitously expressed in mammalian cells where it is predominantly cytoplasmic. Activation occurs through release of the autoinhibitory domain by Ca2 -calmodulin and also requires phosphorylation on a threonine in the activation loop by calmodulin kinase kinase. This upstream enzyme is itself activated by Ca2 -calmodulin. CaMKI has a number of targets that include the cystic fibrosis transmembrane regulator (CFTR) Cl channel. Activation loop phosphorylation may not be essential for some substrates.
CaMKII
a broad-spectrum serine/threonine kinase, CaMKII is the most prominent member of the family. It is widely expressed, with particularly high levels in brain. Unlike other kinases of this family, it has an additional association domain that lies C-terminal to its regulatory domain. This enables it to assemble as a multimeric cylindrical structure consisting of 8–12 copies of
the enzyme as subunits. CaMKII is encoded by four genes, , , , and ; the and subtypes are expressed only in brain. There are also a number of splice variants. As the multimeric structures can assemble as either homomers or heteromers, there is potential for considerable diversity.
Activation of CaMKII occurs when one of the subunits in a multimeric structure binds Ca2 -calmodulin. Its autoinhibitory domain is released from its active site and this allows it to phosphorylate the autoinhibitory domain of the neighbouring subunit at T286. (Note that unlike the other CaM kinases, this is not an activation loop phosphorylation.) Phosphorylation of the neighbouring subunit not only releases its autoinhibitory domain, it also increases its affinity for Ca2 -calmodulin by a factor of more than 1000. This effectively ‘traps’ a second Ca2 -calmodulin and the enzyme can then remain active or
228
Calcium effectors
‘autonomous’ for tens of minutes after the Ca2 stimulus has been removed. It remains autonomous until the bound calmodulin is eventually released and the phosphate at T286 is cleaved by a phosphatase. Moreover, in the face of a train of spikes or oscillations, its level of activation, presumably related to the
number of subunits activated, is matched to the frequency and duration of the Ca2 spikes. This ability to decode Ca2 signals and to become autonomous is thought to underlie the role of CaMKII in learning and memory.
CaMKIII
The protein formerly known as CaMKIII specifically phosphorylates eukaryotic elongation factor 2 (eEF2), a GTPase necessary for the elongation step in protein translation. This kinase has no sequence similarity with the other members of the CaM kinase family and it is now termed eEF2 kinase.
CaMKIV
This is expressed in a limited range of tissues, principally neuronal cells, male germ cells, and lymphocytes, where it regulates gene expression by phosphorylating transcription factors. It is found mostly in the nucleus. It is activated on binding of Ca2 -calmodulin to the autoinhibitory domain, followed by autophosphorylation in the activation loop at by CaM kinase kinase. An important target is the transcription factor CREB which is activated by CaMKIV, but inhibited by CaMKII. CaMKIV can become partly Ca2 -calmodulin-independent when autophosphorylated.
Other Ca2 -calmodulin dependent enzymes
Plasma membrane Ca2 ATPase (PMCA)
The plasma membrane Ca2 ATPases that are responsible for Ca2 homeostasis in the cell were introduced in Chapter 7 (page 190). There are four isoforms. PMCA1 and 4 are ubiquitous, while PMCA2 and PMCA3 are predominant in neuronal cells.12 Together with the SERCAs and the Na -Ca2 exchangers, they maintain cytosol [Ca2 ] in the range 40–100 nmol L 1. Under these conditions, the Ca2 -affinity of the PMCAs is low (KD 10 mol L 1) and therefore they are barely active. When Ca2 is elevated, Ca2 -calmodulin binds to the C-terminal tail of the ATPase, increasing its affinity for Ca2 by a factor of 10, and as a consequence its activity. However, acidic phospholipids, such as phosphatidylserine and PI(4,5)P2, can also increase Ca2 -affinity to an even greater extent, implying that the most active pumps might be localized to membrane domains rich in these lipids. Other potential modulators also interact with PMCAs, such as calcineurin (see below).
Ras guanine nucleotide exchange factor
The principal signalling pathway through the GTPase Ras, described in Chapter 4, involves the targeting of the guanine nucleotide exchange factor Sos to the
229
Signal Transduction
“The nomenclature police insist that the names cyclosporin and cyclosporine should be replaced by ciclosporin. Whether the spelling of its binding protein
ciclophilin remains moot.”
plasma membrane, where it catalyses the exchange of GDP for GTP on Ras. RasGTP activates the ERK/MAPkinase cascade (see page 337) until the bound GTP has been hydrolysed to GDP through the action of a GTPase-activating protein or GAP. While Sos is not in itself Ca2 -dependent, other exchange factors, such as Ras-GRF1 and Ras-GRF2, are. These bring about activation of Ras in response to an elevation of cytosol Ca2 and there is evidence that they require calmodulin in order to respond to a Ca2 signal, although additional inputs are necessary.13 Other Ca2 -sensitive Ras exchange factors (RasGEFs) and RasGAPs that are not calmodulin-dependent are discussed below.
Calcineurin
Calcineurin is a calmodulin-dependent serine/threonine phosphatase. It exists as a heterodimer in mammalian cells (Figure 8.4) and it has a number of specific targets, most notably the transcription factor NFAT (nuclear factor of activated T cells), which functions in immune, muscle, and neuronal cells (see page 521). The catalytic subunit, calcineurin A, is also familiar as protein phosphatase
2B. The regulatory subunit, calcineurin B, possesses four EF-hands and binds Ca2 , but Ca2 -calmodulin is also required to release an autoinhibitory chain from the active site on calcineurin A.14
The immunosuppressive drugs ciclosporin A and tacrolimus (originally known as FK506) are used to prevent organ rejection after transplant surgery. They bind to cytosolic proteins termed immunophilins (cyclophilin A and
Fig 8.4 The calcineurin heterodimer complexed with cyclophilin A and the drug ciclosporin A.
The regulatory subunit, calcineurin B (CnB, green), resembles calmodulin, having EF-hand binding sites for four Ca2 ions (blue spheres). The catalytic site on the calcineurin A subunit (CnA, red) is indicated by a star. The autoinhibitory helix that normally covers this site and the sequence that binds Ca2 -calmodulin are not shown. It is not necessary for all four Ca2 binding sites on CnB to be occupied for activity. (1mf8.16)
230
Calcium effectors
FKBP12 respectively). The drug–protein complex binds to calcineurin as shown in Figure 8.4 and prevents substrate from gaining access to the active site. In this way they prevent the activation of T lymphocytes through the dephosphorylation of the transcription factor NFAT. It should be noted that immunophilins are not restricted to cells of the immune system. They also influence cell growth and repair in nerves15 and they are abundant in other cells as components of ryanodine and IP3 receptor complexes (see page 200).
Another target of calcineurin is the inhibitory-1(I-1) subunit of protein phosphatase 1 (PP1). I-1 acts as an inhibitory pseudosubstrate and when it is dephosphorylated by calcineurin, it is released from the phosphatase and the inhibition is lifted. As PP1 has multiple targets, this expands the range of phosphoproteins that may be dephosphorylated when calcineurin is activated (see page 679).
The effective Ca2 affinity of calcineurin is high, allowing it to be activated by a mild increase in concentration. It then remains active until the level subsides. By contrast, CaMKII (see above) has low Ca2 affinity and responds most effectively to one or more sharp transients, after which it can remain autonomous for tens of minutes. Thus CaMKII responds best to the intense Ca2 transients that occur close to the mouths of open channels, but not to a mild more generalized elevation of Ca2 in the bulk cytosol. Conversely, calcineurin is most effectively activated by a sustained Ca2 increase in the cytosol, where its target transcription factors await dephosphorylation. Thus
the two effectors are sensitive to Ca2 signals that have different temporal and spatial characteristics. For example, in neurons undergoing mild stimulation, there will only be local activation of Ca2 -effectors, such as the CaM kinases, because Ca2 ions entering through channels are restricted to microdomains by local buffers and pumps. Alternatively, strong stimulation, generating a global and longer-lasting Ca2 increase, may activate transcription that leads to the modulation synaptic strength.
Ca2 -calmodulin-sensitive adenylyl cyclases and phosphodiesterase
Ca2 - and cAMP-mediated signalling pathways are linked through the Ca2 -dependent isoforms of adenylyl cyclase (AC) described in Chapter 5. AC1 and AC8 are activated by Ca2 -calmodulin, while AC5 and AC6 are inhibited by Ca2 , independently of calmodulin. The Ca2 -sensitive ACs occupy regions of the plasma membrane rich in cholesterol and glycosphingolipids (lipid rafts, see page 522). This keeps them close to the channels that admit Ca2 and to other signalling proteins. They also encounter molecules of cyclic nucleotide phosphodiesterase 1 (PDE1), a Ca2 - and calmodulin-dependent terminator of cAMP signalling. Consequently, when Ca2 enters neurons through voltage-dependent plasma membrane channels (e.g. L-type channels), it can stimulate AC1 or AC8 to produce cAMP, which is then broken
231
Signal Transduction
Trinitroglycerol, as a precursor of NO, has been in use as a palliative for angina (also as an explosive) since the 1870s.25 It is
now commonly applied sublingually for acute treatment, or as skin patches. The NO is released at the site of application and diffuses to the heart (and other organs) within minutes.
down by PDE1. Thus, a localized Ca2 signal can generate a brief and localized cAMP signal. AC1 and AC8 are also sensitive to oscillatory Ca2 signals and are thought to have roles in learning and memory.
Nitric oxide synthase
It was initially surprising to find that nitric oxide (NO), familiar as a noxious gas, has an important role as an intercellular messenger. NO was first perceived as endothelium-derived relaxing factor (EDRF) in the vascular system.17 It is formed by the oxidation of l-arginine by the haem protein nitric oxide synthase (NOS). There are three members of the NOS family: the membrane-bound endothelial enzyme called eNOS (or NOS III), a soluble enzyme first characterized in brain called nNOS (or NOS I), and in macrophages a cytokine-inducible form called iNOS (or NOS II).18 nNOS is most apparent in nerve and skeletal muscle, though not restricted to these cell types. eNOS is present in a wide variety of cells. Both eNOS and nNOS are Ca2 -calmodulin-dependent enzymes and produce NO in response to a rise in cytosol Ca2 . By contrast, the transcriptionally regulated iNOS binds calmodulin at resting Ca2 levels and is constitutively active. It has high output and, for example in macrophages, it can remain activated for many hours, maximizing the cytotoxic damage that these cells can inflict.
NO is by no means a classical messenger molecule. It diffuses rapidly in solution and because it is short-lived in vivo, it has mostly short-range (paracrine) effects.19 It can readily cross cell membranes to reach
neighbouring cells and these can be activated without the need for plasma membrane receptors. A wide range of cells are affected by NO. For example, as mentioned above, it is a potent smooth muscle relaxant, not only in the vasculature, but also in the bronchioles, gut, and genitourinary tract. In intestinal tissue, nNOS in varicosities of myenteric neurons is activated by an influx of Ca2 . The NO formed diffuses into neighbouring smooth muscle cells, where at nanomolar concentrations it activates a soluble guanylyl cyclase (also a haem protein) that forms cyclic GMP (cGMP).20,21 This then activates cGMP-dependent kinase I (G kinase) which brings about relaxation
by interacting with the mechanisms that regulate the cytosol Ca2 , essentially keeping it low.22 In the cardiovascular system, eNOS in endothelial cells responds to Ca2 in a similar way, to relax vascular smooth muscle and reduce blood pressure.23,24 (Note: as well as stimulating vasodilatory responses, NO has a homeostatic role in the regulation of vascular tone).
In the central nervous system, nNOS is tethered close to NMDA-type glutamate receptors (see page 209) so that it can respond to the transient but intense increases in Ca2 concentration that occur in the vicinity of the open channels.26 The NO that is formed has the potential of acting as either an anterograde or retrograde messenger.27 Because of its diffusibility, it may also influence other cells in the vicinity such as glial cells. All this may have implications for synaptic plasticity (the modulation of synaptic potency).28
232
